The Board of GlaxoSmitheKline Consumer Nigeria Plc (GSK) says it plans to shut down its production facility in Agbara by the third quarter of 2021.
The plan is part of the leading pharmaceutical company’s restructuring efforts, which would see it focus on building “a more sustainable commercial business”.
More details shortly…